NCT05456581Completed
Scotoma Perimetry Oculomotor Training
New Methods to Quantify and Train Eye Movement Strategies in Macular Degeneration
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
The proposed research is relevant to public health because a greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function and preservation of sight. Declines in vision are particularly common in older adults and thus increasing our understanding of how to cre- ate effective means of improving vision is also highly relevant to the mission of the NIA to support research on aging and the health and well-being of older people.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 7 Jul 2022
- Start date
- 1 Nov 2022
- Primary completion date
- 4 Jun 2025
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Macular degeneration
- NCT number
- NCT05456581
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 1 Nov 2022 to the primary completion date, 4 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to sit still in eye tracker for extended periods
- Inability to visualize iris on video eye tracker
- Bilateral retinal scotomas larger than 20° diameter
Who the study is looking for
- Severely impaired vision in both eyes (20/100 or worse)
- Diagnosis of Macular Degeneration
- Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser ophthalmoscope (SLO, MAIA)
- Medical record review indicates this disease severity level has been present for at least 2 years.
Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UAB Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.